John A. Bartholdson

CIK 1382909 · Chairman · last filed 2026-06-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$159.69M

Companies

4

Total Filings

33

Lifetime Open-Market Net

-$2.90M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BVS Director 7,051,259 $8.51 $60.01M $6.60M 14 2026-06-04
OFIX 10%+ Owner 45,426 $9.31 $422.9K $7.77M 1 2026-05-29
LINC Chairman 2,150,769 $46.15 $99.26M -$17.27M 10 2026-05-08
Obagi Medical Products, Inc. (OMPI) Delisted Director 17,953 $0 7 2012-06-08

Recent Filings · Page 4 of 4

33 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2009-06-22 Obagi Medical Products, Inc. (OMPI) Delisted Grant (A) +4,055 $0 EDGAR
2008-06-12 Obagi Medical Products, Inc. (OMPI) Delisted Grant (A) +3,457 $0 EDGAR
2007-06-11 Obagi Medical Products, Inc. (OMPI) Delisted Grant (A) +2,563 $0 EDGAR
Showing 3133 of 33
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.